Clidinium bromide

Clidinium bromide
Clinical data
AHFS/Drugs.comMonograph
MedlinePlusa601036
Routes of
administration
Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
BioavailabilityLow
ExcretionRenal and biliary
Identifiers
  • 3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-1-methyl-1-azabicyclo[2.2.2]octan-1-ium bromide
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H26NO3+
Molar mass352.454 g·mol−1
3D model (JSmol)
  • O=C(OC2C1CC[N+](CC1)(C)C2)C(O)(c3ccccc3)c4ccccc4
  • InChI=1S/C22H26NO3/c1-23-14-12-17(13-15-23)20(16-23)26-21(24)22(25,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-11,17,20,25H,12-16H2,1H3/q+1 checkY
  • Key:HOOSGZJRQIVJSZ-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Clidinium bromide (INN) is an anticholinergic (specifically a muscarinic antagonist) drug.[1][2] It may help symptoms of cramping and abdominal/stomach pain by decreasing stomach acid, and slowing the intestines. It is commonly prescribed in combination with chlordiazepoxide (a benzodiazepine derivative) using the brand name Librax,Normaxin CC.

  1. ^ "Clidinium bromide". Drugs.com. Retrieved August 24, 2013.
  2. ^ Aronson JK (2016). "Clidinium bromide". Meyler's side effects of drugs: the international encyclopedia of adverse drug reactions and interactions (Sixteenth ed.). Amsterdam: Elsevier. p. 404. ISBN 978-0-444-53716-4.